Literature DB >> 18023622

Spinal arteriovenous fistulae with a concomitant cauda equina schwannoma.

Kuang-Chen Hung1, Yung-Hsiao Chiang.   

Abstract

BACKGROUND: Perimedullary spinal arteriovenous malformations or direct spinal arteriovenous fistulaes (AVFs) may be associated with other vascular abnormalities, such as arteriovenous malformations, venous ectasis, and aneurysms, but rarely have been reported with intraspinal intradural tumors.
PURPOSE: The authors present an interesting case of type IV-A spinal AVF concomitant with a cauda equina schwannoma. STUDY
DESIGN: The diagnostic procedures and surgical outcome were described.
METHODS: The patient underwent surgery, the vessel feeding the AVFs was identified and cauterized, and the spinal tumor was removed. The fistula was small and located inside the tumor. The pathology revealed AVF and schwannoma, respectively.
RESULTS: After surgery, the patient's symptoms began to improve and subside. Two years after surgery, follow-up magnetic resonance imaging showed no vascular lesion and tumor in the spinal canal.
CONCLUSIONS: The association of spinal AVFs and cauda equina schwannoma has not been reported previously in any literature. The patient presents the symptoms of myelopathy associated with a spinal vascular lesion; it has to be noted that a concomitant and related intradural spinal tumor may exist.

Entities:  

Mesh:

Year:  2007        PMID: 18023622     DOI: 10.1016/j.spinee.2006.10.022

Source DB:  PubMed          Journal:  Spine J        ISSN: 1529-9430            Impact factor:   4.166


  2 in total

1.  Study and therapeutic progress on spinal cord perimedullary arteriovenous fistulas.

Authors:  Tiefeng Ji; Yunbao Guo; Lei Shi; Jinlu Yu
Journal:  Biomed Rep       Date:  2017-07-25

2.  Concomitant spinal dural arteriovenous fistula and nodular fasciitis in an adolescent: case report.

Authors:  Chan-Lin Chu; Yu-Jen Lu; Tsong-Hai Lee; Shih-Ming Jung; Yu-Cheng Chu; Ho-Fai Wong
Journal:  BMC Pediatr       Date:  2022-01-08       Impact factor: 2.125

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.